Loading...
Loading...
Herbalife Ltd.
, set to post earnings Thursday, is a "powerfully attractive" stock at its current price, according to a long-time bull.
Pivitol Research's Timothy S. Ramey reiterated a Buy and $75 target on the stock Monday and said the company is "clearly a sensible, ethical business," despite a pending investigation by the Federal Trade Commission.
Ramey has been positive on Herbalife since at least last January, when he issued a bullish note at his former employer, D.A. Davidson.
Herbalife shares are down nearly 49 percent since then, partly from a high-decibel short campaign by William A. Ackman's Pershing Square Capital.
Herbalife closed Monday down 3.7 percent at $34.10.
Ackman has characterized Herbalife's multi-level marketing model as an illegal pyramid scheme.
With about 80 percent of Herbalife's business derived in non-U.S. markets, Ramey said the strengthening dollar makes the company's November guidance for the fourth quarter earnings of $1.30 to $1.40 a share is "stale."
Analysts on average expect earnings of $1.22 a share, on sales of $1.16 billion.
For 2015, Ramey expects Herbalife sales will fall 3.4 percent on a 2.1 percent increase in volume offset by a 5.5 percent currency headwind.
"Yet the stock remains very cheap," Ramey said, adding that investors with a 12-to-18-month horizon will be "well-rewarded."
Handicapping the risk of the FTC investigation is "very difficult," Ramey said, but he added that an adverse outcome is "unlikely."
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in